HOME >> BIOLOGY >> NEWS
$6.5 million gift to establish hereditary cancer center at Georgetown University

Washington, DC -- As scientists continue to uncover the lifestyle and genetic factors that play a role in who develops cancer, a newly established center at Georgetown University may help current and future patients better understand their own genetic risk.

A $6.5 million gift from the Robert M. Fisher Memorial Foundation, Inc. will allow Georgetown to strengthen its position as one of the leading hereditary cancer research, treatment and educational programs in the country. The establishment of the Jess and Mildred Fisher Center for Familial Cancer (Fisher Center) will substantially expand both the clinical and research programs at Georgetown's Vincent T. Lombardi Comprehensive Cancer Center, allowing the cancer center to conduct more research on genetic predisposition to cancer, provide increased clinical trial opportunities and allow physicians to evaluate and treat more patients.

Of the $6.5 million gift, $1.5 million will endow the Cecilia F. Rudman Arts and Humanities Program Fund, substantially expanding the reach and scope of the cancer center's current arts therapy program. This is the largest gift to Lombardi's arts and humanities program in its history.

On the Cutting Edge of Cancer Research, Prevention and Treatment
The Fisher Center will be co-directed by Claudine Isaacs, MD, and Marc Schwartz, PhD, associate professors of medicine and oncology at Georgetown. Both Isaacs and Schwartz are nationally recognized cancer researchers, particularly in the area of genetic predisposition and susceptibility for breast cancer, one of the most common hereditary cancers.

"The Fisher Center at Lombardi will be a pioneer in understanding, treating and preventing hereditary cancer. Through prevention, screening and early-detection trials, our ultimate goal is to prevent high-risk patients from ever developing cancer," Isaacs said.

As part of the gift, Lombardi will be among the first cancer centers i
'"/>

Contact: Laura Cavender
lsc6@georgetown.edu
202-687-5100
Georgetown University Medical Center
15-Aug-2006


Page: 1 2 3 4

Related biology news :

1. US Department of Defense awards $1.6 million for implantable biochip research
2. Nottingham biosciences million pound injection
3. $9 million EPSCoR grant to foster integrated research
4. 20 Kentucky firms share $1.9 million from state to match federal SBIR-STTR awards
5. $125 million bioenergy initiative powered by Midwest ag industry, MSU research
6. UC Davis is partner in new $125 million federal bioenergy research center
7. Energy department selects 3 Bioenergy Research Centers for $375 million in federal funding
8. The BBVA Foundation commits 2.4 million euros to research in Ecology and Conservation Biology
9. New $1.16 million study investigates how dietary iron is used by cells
10. 5.9 million award gives UK aging research a new lease on life
11. NIH awards nearly $21 million to fund cutting-edge research equipment

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/8/2016)... , March 8, 2016   Valencell ... technology, today announced it has secured $11M in ... GII Tech, a new venture fund being launched ... additional participation from existing investors TDF Ventures and ... funds to continue its triple-digit growth and accelerate ...
(Date:3/3/2016)... MONTEREY, Calif. , March 3, 2016 /PRNewswire/ ... Partner, launched this week highlighting advancements in flexible, ... – a record setting attendance - have gathered ... in this fast-growing field of electronics. The Flex ... a focal point for companies, R&D organizations, and ...
(Date:3/2/2016)... March 2, 2016 ... addition of the  "Global Biometrics Market in ... ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , Global biometrics ... at a CAGR of around 27%   ... has announced the addition of the  "Global ...
Breaking Biology News(10 mins):
(Date:5/4/2016)... N.J. , May 4, 2016  Bayer ... its oncology compound Stivarga ® (regorafenib) tablets ... carcinoma (HCC) has met its primary endpoint of ... study, called RESORCE, evaluated the efficacy and safety ... has progressed after treatment with sorafenib. The safety ...
(Date:5/4/2016)... New York, NY (PRWEB) , ... May 04, ... ... growth, has leveraged recent innovations in biotechnology to help treat hormonal and stress ... hair loss, Nutrafol® has captured the hearts of key opinion leaders in the ...
(Date:5/3/2016)... ... 03, 2016 , ... Leading CEOs from biotech, pharmaceutical, and ... June 1st at The Four Seasons Hotel Boston. , The Boston CEO Conference ... exclusive access to key decision makers who influence deal making and investment. Attendees ...
(Date:5/3/2016)... -- - And Other Rising Companies - ... Competitor Biologics  - Biosimilar Drug Producers - ... Who are the most important and promising ... sales potentials? Discover, in our updated survey, organisations, outlooks ... revenue forecasting. Visiongain,s new study ...
Breaking Biology Technology:
Cached News: